The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus

December 19, 2024 updated by: Muhammad Naveed Babur, Superior University
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

If inflammation cause in lungs breathing process become disturbed. If damages the air sacs (alveoli) that cause emphysema. COPD mainly starts with asymptomatic patients who do not realize that they have it. It mostly affects older people or middle-aged. Its symptoms become develop slowly but with the time they become worsen, patient change their life style and treatment become helpful to prevent from chronic disease The Detection of Chronic Obstructive Pulmonary Disease in Patients with Diabetes Mellitus.

Methods: The Study design was cross sectional and carried out in hospital, Lahore from July 2024 to Jan 2024. All eligible patients who were Diabetes Mellitus in the study through random sampling technique.

Study Type

Observational

Enrollment (Actual)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan
        • Gulab devi hospital, Ferozepur Rd, Nishtar Town

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Aim is to access the Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus

Description

Inclusion Criteria:

  • Age: 30-65 years Gender: Both
  • Male and female
  • At least 5-10 year history of Diabetes Mellitus
  • Chronic Obstructive Pulmonary Disease

Exclusion Criteria:

  • Patients who smoke prolong.
  • Patient having other diseased (asthma, lung carcinoma).
  • Patients having Acute Respiratory Distress Syndrome (ARDS)."

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
copd
Time Frame: 12 Months
The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2024

Primary Completion (Actual)

August 1, 2024

Study Completion (Estimated)

March 2, 2025

Study Registration Dates

First Submitted

December 19, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSAHS/Batch-Spring23/039

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe